Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

BioCardia, Inc. - Common Stock (NQ:BCDA)

1.535 +0.025 (+1.64%)
Streaming Delayed Price Updated: 2:04 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about BioCardia, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Unusual volume stocks are being observed in Tuesday's session.
On Tuesday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
Let's take a look at the stocks that are in motion in today's session.
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Here are the top movers in Thursday's session.
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Earnings Scheduled For November 13, 2024
 
Via Benzinga
Peering Into BioCardia's Recent Short Interest
 
Via Benzinga
Gold Falls Over 1%; Darden Posts Downbeat Earnings
 
Via Benzinga
Traders are paying attention to the gapping stocks in Thursday's session.
In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
Nasdaq Surges 100 Points; US Initial Jobless Claims Fall
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why BioCardia (BCDA) Stock Is Falling Today
BioCardia shares are trading lower by 12% during Friday's session. The company announced the pricing of an upsized public offering. 
Via Benzinga
BCDA Stock Earnings: BioCardia Reported Results for Q2 2024
BioCardia just reported results for the second quarter of 2024. 
Via InvestorPlace
BioCardia Narrows Loss in Fiscal Q2
Via The Motley Fool
Topics Intellectual Property
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Earnings Scheduled For August 11, 2025
 
Via Benzinga
Earnings Scheduled For May 14, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For March 26, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Crude Oil Moves Higher; Dollar General Earnings Miss Estimates
 
Via Benzinga
Topics Earnings
Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings
 
Via Benzinga
Dow Jumps Over 100 Points; Nvidia Earnings Top Views
 
Via Benzinga
Topics Stocks
Why BioCardia (BCDA) Stock Is Up 95% Today
BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA Steerable Introducer product family. 
Via Benzinga
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are worth diving into on Monday and we have all of the latest news worth knowing about this morning! 
Via InvestorPlace
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.